Tracing down the Updates on Dengue Virus—Molecular Biology, Antivirals, and Vaccine Strategies
Background: Nearly half of the world is at risk of developing dengue infection. Dengue virus is the causative agent behind this public healthcare concern. Millions of dengue cases are reported every year, leading to thousands of deaths. The scientific community is working to develop effective therap...
Main Authors: | Shiza Malik, Omar Ahsan, Hassan Mumtaz, Muhammad Tahir Khan, Ranjit Sah, Yasir Waheed |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/8/1328 |
Similar Items
-
Problematic questions in the development of specific prevention of dengue fever
by: E. I. Kazachinskaia, et al.
Published: (2022-03-01) -
Dengue virus serotype did not contribute to clinical severity or mortality in Taiwan’s largest dengue outbreak in 2015
by: Jih-Jin Tsai, et al.
Published: (2023-11-01) -
Autochthonous Dengue Fever in 2 Patients, Rome, Italy
by: Serena Vita, et al.
Published: (2024-01-01) -
Dengue fever as an emerging disease in Afghanistan: Epidemiology of the first reported cases
by: Mohammad Nadir Sahak
Published: (2020-10-01) -
Natural Products as Source of Potential Dengue Antivirals
by: Róbson Ricardo Teixeira, et al.
Published: (2014-06-01)